Julie Rubinstein, President and COO at Adaptive Biotechnologies Corp (ADPT), sold 35,643 shares at $27.57 ($1.0M) on 2026-10-01, disclosed to the SEC on 2026-10-05.
Scheduled sale ($1.0M) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.57 | 6,081 | $168K | 16.5% |
| 2 | $28.56 | 5,800 | $166K | 16.3% |
| 3 | $28.13 | 11,881 | $334K | 32.9% |
| 4 | $28.82 | 6,699 | $193K | 19.0% |
| 5 | $29.67 | 5,182 | $154K | 15.2% |
| Total | $28.46 avg | 35,643 |
| $1.0M |
| 100% |
| Filing → |
| ADPT | SELL | 2026-04-24 | $798K | — | Filing → |
| ADPT | SELL | 2026-04-21 | $1.0M | — | Filing → |
| ADPT | SELL | 2026-04-16 | $826K | — | Filing → |